Abiopharma

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

TWO Determines Unsolicited Proposal from CrossCountry Mortgage is a “Company Superior Proposal”

State Street Elects Susan Gordon to Its Board of Directors

Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease

BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Ford and Major League Baseball Unite to Celebrate America’s Pastime and the People Who Power It

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851

FuelCell Energy Scales Up for Data Centers with Packaged 12.5 MW Utility‑Grade Power Block Solution and Manufacturing Expansion Plans